Article,
Diagnosis of Assymptom Uterine Leuomyoma in Premenopausal Women
CENTRAL ASIAN JOURNAL OF MEDICAL AND NATURAL SCIENCE, 4 (4): 95-100 (June 2023)
Abstract
The article presents the evaluation of the effectiveness of immunomodulatory therapy in women with asymptomatic uterine leiomyoma. In this article, we was studied 67 women who were treated with asymptomatic uterine leiomyoma. By age, all patients were identical, the average age was 29.6 +_1,2 years. As the main method of investigation, IFA was used, diagnostic test systems were used to determine serum lymphocytes with an activation marker in women with asymptomatic uterine leiomyoma CD25, CD71, CD95, lactoferrin, proinflammatory cytokines IL-6, IL-8, IL-18, IL-10, TNF. Complex treatment with an immunomodulator for asymptomatic uterine leiomyoma normalized the level of lactoferrin in the composition of lymphocytes. The use of the immunomodulatory drug Likopid in complex therapy contributed to the restoration of altered parameters of the immune system, which in turn made it possible to optimize reproductive health. After complex treatment, 60.0% of women diagnosed with asymptomatic uterine fibroids became pregnant and gave birth to healthy children.
